Literature DB >> 20660104

Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice.

Dilara Jappar1, Shu-Pei Wu, Yongjun Hu, David E Smith.   

Abstract

The purpose of this study was to evaluate the role, relevance, and regional dependence of peptide transporter (PEPT) 1 expression and function in mouse intestines using the model dipeptide glycylsarcosine (GlySar). After isolating specific intestinal segments, in situ single-pass perfusions were performed in wild-type and Pept1 knockout mice. The permeability of [(3)H]GlySar was measured as a function of perfusate pH, dipeptide concentration, potential inhibitors, and intestinal segment, along with PEPT1 mRNA and protein. We found the permeability of GlySar to be saturable (K(m) = 5.7 mM), pH-dependent (maximal value at pH 5.5), and specific for PEPT1; other peptide transporters, such as PHT1 and PHT2, were not involved, as judged by the lack of GlySar inhibition by excess concentrations of histidine. GlySar permeabilities were comparable in the duodenum and jejunum of wild-type mice but were much larger than that in ileum (approximately 2-fold). A PEPT1-mediated permeability was not observed for GlySar in the colon of wild-type mice (<10% residual uptake compared to proximal small intestine). Moreover, GlySar permeabilities were very low and not different in the duodenum, jejunum, ileum, and colon of Pept1 knockout mice. Functional activity of intestinal PEPT1 was confirmed by real-time polymerase chain reaction and immunoblot analyses. Our findings suggest that a loss of PEPT1 activity (e.g., due to polymorphisms, disease, or drug interactions) should have a major effect in reducing the intestinal absorption of di-/tripeptides, peptidomimetics, and peptide-like drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660104      PMCID: PMC2957162          DOI: 10.1124/dmd.110.034025

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  36 in total

1.  Calculation of the aqueous diffusion layer resistance for absorption in a tube: application to intestinal membrane permeability determination.

Authors:  J H Kou; D Fleisher; G L Amidon
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

2.  Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities.

Authors:  D A Johnson; G L Amidon
Journal:  J Theor Biol       Date:  1988-03-07       Impact factor: 2.691

3.  Hypericin-induced phototoxicity of human leukemic cell line HL-60 is potentiated by omeprazole, an inhibitor of H+K+-ATPase and 5'-(N,N-dimethyl)-amiloride, an inhibitor of Na+/H+ exchanger.

Authors:  L Mirossay; A Mirossay; E Kocisová; I Radváková; P Miskovský; J Mojzis
Journal:  Physiol Res       Date:  1999       Impact factor: 1.881

4.  Expression cloning of a mammalian proton-coupled oligopeptide transporter.

Authors:  Y J Fei; Y Kanai; S Nussberger; V Ganapathy; F H Leibach; M F Romero; S K Singh; W F Boron; M A Hediger
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

5.  Effect of 5-(N,N-Dimethyl)-amiloride, a specific inhibitor of Na(+)/H(+) exchanger, on the palmitoyl-L-carnitine-induced mechanical and metabolic derangements in the isolated perfused rat heart.

Authors:  J Arakawa; A Hara
Journal:  Pharmacology       Date:  1999-11       Impact factor: 2.547

6.  Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney.

Authors:  W Liu; R Liang; S Ramamoorthy; Y J Fei; M E Ganapathy; M A Hediger; V Ganapathy; F H Leibach
Journal:  Biochim Biophys Acta       Date:  1995-05-04

7.  Characterization of the oral absorption of beta-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ.

Authors:  P J Sinko; G L Amidon
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

8.  Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization.

Authors:  R Liang; Y J Fei; P D Prasad; S Ramamoorthy; H Han; T L Yang-Feng; M A Hediger; V Ganapathy; F H Leibach
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

9.  Characteristics of glycylsarcosine transport in rabbit intestinal brush-border membrane vesicles.

Authors:  V Ganapathy; G Burckhardt; F H Leibach
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

10.  Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes.

Authors:  S Matsumoto; H Saito; K Inui
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

View more
  33 in total

1.  In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.

Authors:  Bei Yang; David E Smith
Journal:  Pharm Res       Date:  2017-08-02       Impact factor: 4.200

2.  In vivo absorption and disposition of cefadroxil after escalating oral doses in wild-type and PepT1 knockout mice.

Authors:  Maria M Posada; David E Smith
Journal:  Pharm Res       Date:  2013-11       Impact factor: 4.200

3.  Expression and regulation of proton-coupled oligopeptide transporters in colonic tissue and immune cells of mice.

Authors:  Yuqing Wang; Yongjun Hu; Ping Li; Yayun Weng; Nobuhiko Kamada; Huidi Jiang; David E Smith
Journal:  Biochem Pharmacol       Date:  2018-01-03       Impact factor: 5.858

4.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

5.  Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.

Authors:  Tuba Incecayir; Yasuhiro Tsume; Gordon L Amidon
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

6.  Plasma concentrations and ACE-inhibitory effects of tryptophan-containing peptides from whey protein hydrolysate in healthy volunteers.

Authors:  Melanie Martin; Diana Hagemann; Thinh Trung Nguyen; Lisa Schwarz; Sherif Khedr; Mats Leif Moskopp; Thomas Henle; Andreas Deussen
Journal:  Eur J Nutr       Date:  2019-05-03       Impact factor: 5.614

7.  Impact of intestinal PepT1 on the kinetics and dynamics of N-formyl-methionyl-leucyl-phenylalanine, a bacterially-produced chemotactic peptide.

Authors:  Shu-Pei Wu; David E Smith
Journal:  Mol Pharm       Date:  2013-01-07       Impact factor: 4.939

8.  Relevance of PepT1 in the intestinal permeability and oral absorption of cefadroxil.

Authors:  Maria M Posada; David E Smith
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

9.  Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.

Authors:  Olena Kis; Jason A Zastre; Md Tozammel Hoque; Sharon L Walmsley; Reina Bendayan
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

10.  Functional and molecular expression of the proton-coupled oligopeptide transporters in spleen and macrophages from mouse and human.

Authors:  Dongli Sun; Yuqing Wang; Fuqing Tan; Danbo Fang; Yongjun Hu; David E Smith; Huidi Jiang
Journal:  Mol Pharm       Date:  2013-03-13       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.